Trial intelligence / Profile preview

C-Peptide for Diabetic Peripheral Neuropathy

NCT00278980Phase 2Completed

Sponsor
Creative Peptides
Start
Oct 2003
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of C-peptide in diabetic polyneuropathy (DPN), sponsored by Creative Peptides. Started Oct 2003; status: completed.

02

Drugs

C-peptide
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on NCT00278980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00278980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call